abs135.txt	epstein-barr	virus	(ebv)-positive	gastric	adenocarcinoma	exhibits	locally	intenseinflammation	but	systemic	manifestations	are	uncertain		our	study	examinedwhether	circulating	mediators	of	inflammation	and	immune	response	differ	by	tumorebv	status	from	a	latvian	series	302	cancer	cases	we	measured	plasmalevels	92	immune-related	proteins	in	the	28	patients	with	ebv-positive	tumorsand	34	ebv-negative	tumors	eight	markers	were	statisticallysignificantly	higher	tumor	ebv	positivity	chemokine	c-c	motif	ligand	(ccl)20	(odds	ratio	(or)	=	3	6	p-trend	0	001)	c-x-c	9	(or	=3	003)	programmed	death-ligand	1	(pd-l1	or	4	=0	004)	interleukin	(il)-10	2	019)	ccl19	p-trend=	ccl11	026)	il-17a	038)and	ccl8	049)	responses	to	gastriccancer	characterized	alterations	chemokines	pd-l1	profiling	ofthese	molecules	may	enable	non-invasive	diagnosis	when	tissueis	unavailable	findings	provide	theoretical	justification	for	clinicalevaluations	checkpoint	therapy
